OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 17

Showing 17 citing articles:

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 15

The Indissociable Triad: Vascular Impairment, Muscle Atrophy, and Cognitive Decline
Enzo Pereira de Lima, Masaru Tanaka, Caroline Barbalho Lamas, et al.
(2024)
Open Access | Times Cited: 10

Vascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
Enzo Pereira de Lima, Masaru Tanaka, Caroline Barbalho Lamas, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2096-2096
Open Access | Times Cited: 5

The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
Nada H. Aljarba, Hayder M Al-Kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 222, pp. 111236-111236
Open Access

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access

ECHS1-NOX4 interaction suppresses rotenone-induced dopaminergic neurotoxicity through inhibition of mitochondrial ROS production
Zirui Zhao, Ruonan Wang, Haitao Ge, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Suad Hamdan Almasoudi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025) Vol. 224, pp. 111296-111296
Open Access

The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects
Saad Misfer Alqahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177510-177510
Open Access

Neuroprotective Effect Of Thymus Vulgaris On Paraquat Induced Parkinson’s Disease
Naheed Akhter, Iqra Rafiq, Amer Jamil, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151740-151740
Closed Access

Dysregulation of proBDNF/p75NTR and BDNF/TrkB Signaling in Acute Ischemic Stroke: Different Sides of the Same Coins
Hala Alnoaman, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111338-111338
Open Access

Epigenetics is involved in the pleiotropic effects of statins
Cezar Kayzuka Cotta Filho, Vitória Carolina Rondon-Pereira, C. Tavares, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access

Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil
Saad Misfer Alqahtani, Hayder M Al-Kuraishy, Ali I. Al‐Gareeb, et al.
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access

The effect of supplementation of vitamin D on hyperlipidemia and bone mass in the pediatric with obesity
Feifan Wang, Lingshan Bei, Xiaoyan Zhang, et al.
Critical Reviews in Immunology (2024) Vol. 45, Iss. 1, pp. 31-39
Closed Access | Times Cited: 1

MODELING OF PARKINSON'S DISEASE BY INTRASTRIATAL ADMINISTRATION OF STREPTOZOTOCIN
Jelena Osmanović Barilar, Vladimir Papić, Vladimir Farkaš, et al.
Neuropharmacology (2024) Vol. 265, pp. 110246-110246
Closed Access | Times Cited: 1

Safety assessment of ezetimibe: real-world adverse event analysis from the FAERS database
Yuchen Han, Siyuan Cheng, Jinzheng He, et al.
Expert Opinion on Drug Safety (2024)
Closed Access | Times Cited: 1

Statins for vascular dementia: A hype or hope
Haroon Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access | Times Cited: 1

Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS)
Hongbing Wan, Xiuxiu Xu, Dasong Yi, et al.
Expert Opinion on Drug Safety (2024), pp. 1-10
Closed Access

Page 1

Scroll to top